Skip to main content
Caplight Logo









Valyrian

Valyrian

Overview

Valyrian is an early-stage venture fund focused on investing in Thiel Fellows.

Portfolio Companies

3

Investments

Valyrian investments
CompanyDateStageLead
CryopetsFeb 2026SeedLead
Orchard RoboticsSep 2025Series ACo-investor
Keep TechnologiesMay 2025Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Valyrian based?

Headquarters information for Valyrian is not publicly available.

When was Valyrian founded?

Founding year information for Valyrian is not publicly available.

How many portfolio companies does Valyrian have?

Valyrian has 3 portfolio companies in Caplight's dataset.

What are some companies in Valyrian's portfolio?

Recent investments visible on Caplight include Cryopets, Orchard Robotics, Keep Technologies, Cryopets.

What was Valyrian's most recent investment?

Valyrian's most recent investment on Caplight was in Cryopets in 2026.

What sectors does Valyrian focus on?

Valyrian focuses on FinTech, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Consumer & Commerce.

What company stages does Valyrian focus on?

Valyrian typically invests at the Early stage.

Firmographic Details

Headquarters—
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?